Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study

Authors:

Abstract
In 85% to 90% of patients with multiple sclerosis (MS), the onset of symptoms occurs as a clinically isolated syndrome (CIS).1 Long-term follow-up studies of patients with a CIS have shown that the syndrome eventually converts to clinically definite MS (CDMS) in only 38% to 68% of patients2 and that abnormal magnetic resonance (MR) images at disease presentation are a powerful prognostic tool, as 56% to 88% of patients having a CIS with abnormal images progress to CDMS compared with 19% to 24% with normal images.3-6 In 2001, the modified Barkhof criteria7,8 were incorporated into the diagnostic McDonald criteria,9 allowing earlier diagnosis of MS based on MR imaging–derived measures. The MR imaging criteria included locations in the brain where demyelination typically occurs in MS (periventricular, juxtacortical, and infratentorial) and yielded high specificity and adequate sensitivity in predicting conversion to CDMS.

This publication has 15 references indexed in Scilit: